ENvue Medical, Inc. FEED
0.41
(0.08)
(16.33%)
as of 25 Sep
- Market cap
- $950.0K
- P/E
- 0.0×
Follow FEED
Insider Buys
alert about insiders buying in the last 12 month
| Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
42.59 | 42.59 | 12.95 | 14.07 | 16.20 | 17.60 | 8.88 | 0.86 | 0.67 | 0.57 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(21.87) | (21.87) | (6.12) | (6.65) | (31.81) | (34.57) | (5.02) | (4.02) | (3.13) | (0.54) |
P/B ratio |
16.79 | 16.79 | 3.37 | 3.66 | 4.35 | 4.73 | 2.07 | 0.49 | 2.73 | 0.04 |
Price to Tangible BV |
16.79 | 16.79 | 3.37 | 3.66 | 4.35 | 4.73 | 2.07 | 0.49 | 2.73 | 41.42 |
EV/Sales |
43.06 | 43.06 | 0.91 | 2.03 | 11.67 | 13.07 | 5.32 | (0.56) | 0.39 | (0.67) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 | 0.00 | 0.16 |
EV/Operating CF |
(5.89) | (5.89) | (0.17) | (0.37) | (4.53) | (5.07) | (0.57) | 0.36 | (0.39) | 0.18 |
EV/FCF |
(5.88) | (5.88) | (0.17) | (0.37) | (4.53) | (5.07) | (0.57) | 0.36 | (0.39) | 0.18 |
Quick Ratio |
3.54 | 2.63 | 2.70 | 4.20 | 4.17 | 1.22 | 1.18 | 1.47 | 0.31 | 0.68 |
Current Ratio |
4.49 | 2.75 | 2.75 | 4.38 | 4.38 | 2.42 | 2.42 | 2.64 | 1.22 | 1.09 |
Net Debt/EBITDA |
0.26 | 1.59 | 1.60 | 1.35 | 1.36 | 0.53 | 0.54 | 0.96 | 0.21 | 0.29 |
Debt/Assets |
0.00% | 0.16% | 0.00% | 0.57% | 0.00% | 1.38% | 0.00% | 0.00% | 0.00% | 2.63% |
Debt/Equity |
0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.03 |
Asset Turnover |
0.26 | 0.12 | 0.08 | 0.20 | 0.20 | 0.10 | 0.13 | 0.36 | 0.50 | 0.11 |
Operating CF/Net income |
0.67 | 0.78 | 0.78 | 0.31 | 0.31 | 1.29 | 1.29 | 0.97 | 0.68 | 0.56 |
Capex/Depreciation |
0.00 | 0.00 | (1.00) | 0.00 | (1.50) | 0.00 | (3.00) | (1.00) | (3.00) | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (430.46%) | (231.41%) | (180.78%) | (328.13%) | (226.23%) | (114.14%) | (168.51%) | (102.78%) | (160.56%) | (98.32%) | |
| (284.58%) | (84.27%) | (52.57%) | (169.51%) | (165.65%) | (75.14%) | (92.67%) | (59.13%) | (71.92%) | (74.97%) | |
ROIC |
(32,193.75%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (602.40%) | (304.61%) | 0.00% | (47.18%) |
Return on Tangible Assets |
(404.33%) | (84.75%) | (85.29%) | (219.96%) | (221.63%) | (161.14%) | (165.09%) | (91.86%) | (599.51%) | (2,297.95%) |
Average Days of Receivables |
76.44 | 54.49 | 171.08 | 56.85 | 43.07 | 52.91 | 4.37 | 50.84 | 13.98 | 41.32 |
Research and Development Expense of Revenue |
96.98% | 27.45% | 27.45% | 17.29% | 17.29% | 37.63% | 37.63% | 8.10% | 35.54% | 69.02% |
Selling, General and Administrative Expense of Revenue |
927.92% | 764.37% | 764.37% | 363.42% | 363.42% | 651.06% | 651.06% | 209.72% | 163.45% | 396.63% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.81 |
Share Based Compensation of Revenue |
331.13% | 0.00% | 151.20% | 0.00% | 22.54% | 0.00% | 47.07% | 12.83% | 13.92% | 0.00% |
Graham Net Nets |
0.05 | 0.05 | 0.26 | 0.24 | 0.22 | 0.20 | 0.44 | 1.93 | 0.19 | (0.25) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(29.84%) | (29.84%) | (55.10%) | (50.72%) | (55.14%) | (50.75%) | (83.00%) | (185.31%) | (213.80%) | (1,319.20%) |
Free Cash Flow Yield |
(17.20%) | (17.20%) | (42.13%) | (38.78%) | (15.92%) | (14.65%) | (105.37%) | (182.58%) | (147.02%) | (650.59%) |
Revenue per Share |
1,766.67 | 1.21 | 1,557.50 | 1.35 | 1,695.00 | 0.53 | 683.64 | 1,756.15 | 1,162.73 | 48.81 |
Operating CF per Share |
(12,913.33) | (6.59) | (8,477.50) | (3.47) | (4,367.00) | (4.96) | (6,395.45) | (2,770.77) | (1,143.64) | (179.20) |
Capex per Share |
0.00 | 0.00 | (5.00) | 0.00 | (3.00) | 0.00 | (2.73) | (0.77) | (1.36) | (1.15) |
Free Cash Flow per Share |
(12,913.33) | (6.59) | (8,482.50) | (3.47) | (4,370.00) | (4.96) | (6,398.18) | (2,771.54) | (1,145.00) | (180.34) |
Cash per Share |
4,460.00 | 14.63 | 18,832.50 | 6.15 | 7,737.00 | 1.91 | 2,466.36 | 2,525.38 | 341.82 | 81.34 |
Shareholders Equity per Share |
4,493.33 | 4.65 | 5,985.00 | 5.02 | 6,313.00 | 2.28 | 2,939.09 | 3,067.69 | 285.00 | 640.48 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4,493.33 | 4.65 | 5,985.00 | 5.02 | 6,313.00 | 2.28 | 2,939.09 | 3,067.69 | 285.00 | 640.48 |
Free Cash Flow |
(3.87) | (3.39) | (3.39) | (4.37) | (4.37) | (7.03) | (7.04) | (3.60) | (2.52) | (9.43) |
Working Capital |
1.43 | 5.07 | 5.07 | 6.44 | 6.44 | 3.29 | 3.29 | 4.03 | 0.61 | 0.61 |
Capital Expenditures |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.06) |
Net Current Asset Value |
1.15 | 2.14 | 2.14 | 6.03 | 6.03 | 2.96 | 2.96 | 3.80 | 0.33 | (0.36) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 | 0.00 | 0.07 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
Net Profit Margin |
(1,093.21%) | (694.22%) | (694.38%) | (842.60%) | (842.60%) | (724.47%) | (724.47%) | (162.55%) | (144.84%) | (657.07%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.00 | 0.06 | 0.50 | 0.04 | 0.40 | 0.01 | 0.14 | 0.14 | 0.11 | 101.27 |
Cash ROIC |
(144.38%) | (34.47%) | (34.20%) | (31.36%) | (31.12%) | (118.18%) | (118.43%) | (49.64%) | (183.10%) | (24.44%) |
Accounts Receivable Turnover |
4.40 | 6.11 | 3.24 | 6.10 | 7.31 | 4.87 | 12.75 | 13.96 | 12.30 | 13.19 |
Accounts Payable Turnover |
0.93 | 3.00 | 1.05 | 2.57 | 0.98 | 0.62 | 0.51 | 0.32 | 0.71 | 1.33 |
Inventory Turnover |
2.06 | 3.08 | 2.82 | 5.78 | 5.29 | 0.50 | 0.27 | 0.30 | 0.43 | 1.06 |
Average Days of Payables |
189.10 | 128.51 | 564.01 | 34.33 | 714.22 | 41.18 | 1,381.38 | 1,175.73 | 187.02 | 465.98 |
Days of Inventory on Hand |
177.37 | 129.40 | 129.40 | 69.05 | 69.05 | 1,357.05 | 1,357.05 | 1,336.70 | 761.63 | 355.42 |
Average Receivables |
0.12 | 0.10 | 0.19 | 0.28 | 0.23 | 0.15 | 0.06 | 0.16 | 0.21 | 0.19 |
Average Payables |
0.27 | 0.14 | 0.39 | 0.36 | 0.95 | 0.94 | 1.14 | 2.31 | 1.47 | 1.80 |
Average Inventory |
0.12 | 0.13 | 0.15 | 0.16 | 0.18 | 1.18 | 2.18 | 2.45 | 2.46 | 2.26 |
Average Assets |
2.04 | 5.13 | 8.23 | 8.43 | 8.62 | 7.25 | 5.88 | 6.28 | 5.15 | 22.38 |
Average Common Equity |
1.35 | 1.87 | 2.39 | 4.35 | 6.31 | 4.77 | 3.23 | 3.61 | 2.31 | 17.06 |
Columns are period end dates